Selective role of PI3Kδ in neutrophil inflammatory responses

[1]  B. Vanhaesebroeck,et al.  Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta. , 2003, Cancer research.

[2]  D. Staunton,et al.  Essential Role of Phosphoinositide 3-Kinase δ in Neutrophil Directional Movement , 2003, The Journal of Immunology.

[3]  J. Ihle,et al.  Essential, Nonredundant Role for the Phosphoinositide 3-Kinase p110δ in Signaling by the B-Cell Receptor Complex , 2002, Molecular and Cellular Biology.

[4]  E. Vigorito,et al.  A Crucial Role for the p110δ Subunit of Phosphatidylinositol 3-Kinase in B Cell Development and Activation , 2002, The Journal of experimental medicine.

[5]  K. Okkenhaug,et al.  Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice , 2002, Science.

[6]  L. Kilpatrick,et al.  TNFalpha elicits association of PI 3-kinase with the p60TNFR and activation of PI 3-kinase in adherent neutrophils. , 2001, Biochemical and biophysical research communications.

[7]  S. Green,et al.  Oxidative Metabolism of Murine Macrophages , 1994, Current protocols in immunology.

[8]  Silvano Sozzani,et al.  Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation , 2000 .

[9]  Dianqing Wu,et al.  Roles of PLC-β2 and -β3 and PI3Kγ in Chemoattractant-Mediated Signal Transduction , 2000 .

[10]  W L Stanford,et al.  Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. , 2000, Science.

[11]  U. Maier,et al.  Roles of Non-catalytic Subunits in Gβγ-induced Activation of Class I Phosphoinositide 3-Kinase Isoforms β and γ* , 1999, The Journal of Biological Chemistry.

[12]  S. Jackson,et al.  Competitive and noncompetitive inhibition of the DNA-dependent protein kinase. , 1999, Cancer research.

[13]  M. Waterfield,et al.  Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages , 1999, Nature Cell Biology.

[14]  A. Mócsai,et al.  Adhesion-dependent degranulation of neutrophils requires the Src family kinases Fgr and Hck. , 1999, Journal of immunology.

[15]  S. Hoshino,et al.  Heterodimeric Phosphoinositide 3-Kinase Consisting of p85 and p110β Is Synergistically Activated by the βγ Subunits of G Proteins and Phosphotyrosyl Peptide* , 1997, The Journal of Biological Chemistry.

[16]  Jonathan A. Cooper,et al.  p110δ, a Novel Phosphatidylinositol 3-Kinase Catalytic Subunit That Associates with p85 and Is Expressed Predominantly in Leukocytes* , 1997, The Journal of Biological Chemistry.

[17]  J. Cowland,et al.  Granules of the human neutrophilic polymorphonuclear leukocyte. , 1997, Blood.

[18]  M. Zvelebil,et al.  p110δ, a novel phosphoinositide 3-kinase in leukocytes , 1997 .

[19]  G. Bokoch,et al.  A Tyrosine Kinase Signaling Pathway Accounts for the Majority of Phosphatidylinositol 3,4,5-Trisphosphate Formation in Chemoattractant-stimulated Human Neutrophils* , 1996, The Journal of Biological Chemistry.

[20]  R. Abraham,et al.  Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3‐kinase inhibitors, wortmannin and LY294002. , 1996, The EMBO journal.

[21]  J. Houston,et al.  The six-day-old rat air pouch model of inflammation: characterization of the inflammatory response to carrageenan. , 1994, Journal of pharmacological and toxicological methods.

[22]  K Y Hui,et al.  A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). , 1994, The Journal of biological chemistry.

[23]  A. Chinnaiyan,et al.  In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metalloproteinases 2. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Arcaro,et al.  Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. , 1993, The Biochemical journal.

[25]  C. Laudanna,et al.  Effect of Inhibitors of Distinct Signaling Pathways on Neutrophil O2− Generation in Response to Tumor Necrosis Factor-α, and Antibodies Against CD18 and CD11a: Evidence for a Common and Unique Pattern of Sensitivity to Wortmannin and Protein Tyrosine , 1993 .

[26]  I. Takahashi,et al.  Wortmannin, a microbial product inhibitor of myosin light chain kinase. , 1992, The Journal of biological chemistry.

[27]  J. Gamble,et al.  Adhesion protein GMP140 inhibits superoxide anion release by human neutrophils. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Coligan.  Current protocols in immunology , 1991 .

[29]  P. Taylor,et al.  An inositol tetrakisphosphate-containing phospholipid in activated neutrophils , 1988, Nature.

[30]  S. Weiss,et al.  Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions. , 1986, The Journal of clinical investigation.